期刊文献+

Alzheimer病治疗研究的现状与展望 被引量:2

Current status and prospects of the pharmacotherapy of Alzheimer's disease
下载PDF
导出
摘要 Alzheimer病目前已成为严重危害人类健康的疾病 ,对其治疗研究已愈来愈受到重视 ,并已取得令人瞩目的进展。本文对近年来有关 Increasing interest has f ocused on the pharmacotherapy of Alzheimer's disease,which is one of the disease s seriously imperiling the health of human beings, and considerable progress has already been made in this field. In this paper, current status of the pharmacot herapy of Alzheimer's disease is reviewed.
出处 《药学服务与研究》 CAS CSCD 2002年第3期137-140,共4页 Pharmaceutical Care and Research
关键词 现状 阿尔茨海默病 治疗 发展趋势 Alzheimer disease therapy trends
  • 相关文献

参考文献20

  • 1Fillit HM. The pharmacoeconomics of Alzheimer's disease[J]. Am J Manag Care,2000,6(22 Suppl):S1139.
  • 2Giacobini E. Cholinesterase inhibitors stabilize Alzheimer's disease[J]. Ann N Y Acad Sci,2000,920:321.
  • 3Dooley M, Lamb HM. Donepezil: a review of its use in Alzheimer's disease[J]. Drugs Aging,2000,16(3):199.
  • 4Farlow MR, Cyrus PA. Metrifonate therapy in Alzheimer's disease: a pooled analysis of four randomized, double-blind, placebo-controlled trials[J]. Dement Geriatr Cogn Disord,2000,11(4):202.
  • 5Ishihara Y, Goto G, Miyamoto M. Central selective acetylcholinesterase inhibitor with neurotrophic activity: structure-activity relationships of TAK-147 and related compounds[J]. Curr Med Chem, 2000,7(3):341.
  • 6Maelicke A, Schrattenholz A, Samochocki M, et al. Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease[J]. Behav Brain Res,2000,113(1-2):199.
  • 7Hellstrom-Lindahl E. Modulation of beta-amyloid precursor protein processing and tau phosphorylation by acetylcholine receptors[J]. Eur J Pharmacol, 2000,393(1-3):255.
  • 8Martin-Ruiz CM, Court JA, Molnar E,et al. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease[J]. J Neurochem, 1999,73(4):1635.
  • 9Messer WS Jr, Rajeswaran WG, Cao Y,et al. Design and development of selective muscarinic agonists for the treatment of Alzheimer's disease: characterization of tetrahydropyrimidine derivatives and development of new approaches for improved affinity and selectivity for M1 receptors[J]. Pharm Acta Helv, 2000,74(2-3):135.
  • 10Kem WR. The brain alpha7 nicotinic receptor may be an important therapeutic target for the treatment of Alzheimer's disease: studies with DMXBA (GTS-21)[J]. Behav Brain Res, 2000,113(1-2):169.

同被引文献11

  • 1Munoz DG, Ganapathy CR, Eliasziw M, et al. Educational attainment and socioeconomic status of patients with autopsy - confirmed Alzheimer disease. Arch Neurol, 2000, 57 (1): 85 ~ 9.
  • 2Sala SD,Francescani A,Muggia S.et al.Variableslinked to psychotic symptoms in Alzheimer's disease. Eur J Neurol, 1998, 5(6):553 ~ 560.
  • 3Feldman H. Caregiver burden: an ipmortant concept in the management of Alzheimer's disease. Alzheimer Insights, 1995, 5 (4): 1 ~3.
  • 4Levestone S,Philpot M,Connell J,et al.Genetics,molecular biology,neu-ropathology and phenotype of frontal lobe dementia:A case history[J].Br J Psychiatry,2002;180:455-60.
  • 5Pang PT,Lu B.Regulation of late-phase LTP and long-term memory in normal and aging hippocampus:role of secreted proteins tPA and BDNF[J].Ageing Res Rev,2004;3(4):407-30.
  • 6王建枝,王全保,李先涛,等.Alzheimer病实验模型的研究[J].中国病理生理杂志,2000;16(10):1107.
  • 7Yamada K,Mizuno M.Nabeshima T.Role for brain-derived neurotrophic factor in learning and memory[J].Life Sci,2002;70(3):735-44.
  • 8Schabitz WR,Steigleder T,Cooper-Kuhn CM,et al.Intravenous brain-de-rived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis[J].Stroke,2007;38(7):2165-72.
  • 9Impey S,Obrietan K,Wong ST,et al.Cross talk between ERK and PKA is required for Ca2+stimulation of CREB-dependent transcription and ERK nuclear translocation[J].Neuron,1998;21(4):869-83.
  • 10凌雁武,黄瑞雅.老年性痴呆动物模型的研究进展[J].右江医学,2008,36(6):736-740. 被引量:5

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部